Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. logo
ARWR

Arrowhead Pharmaceuticals, Inc. (ARWR)

$32.020.56%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$31.8
Day's Range
$33.26
$26.81
52-Week Range
$74.77
1 month return7.48%
3 month return18.77%
1 year return54.05%
5 year return861.56%

Company Information

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead's RNAi-based therapeutics leverage this natural pathway of gene silencing.
OrganizationArrowhead Pharmaceuticals, Inc.
Employees397
CEODr. Christopher R. Anzalone Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
72%
Buy
27%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for Arrowhead Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 122.45%

Current

$32.02

Target

$71.23

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
8
15
15
Hold
3
3
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
3.4B
Book Value
$3.76
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.07
PEG Ratio
-1.32
Wall Street Target Price
71.23

Valuation

Trailing PE0.0
Forward PE111.11
Price/Book (mrq)
6.53
Enterprise Value
2.6B
Enterprise Value/Revenue
10.81
Enterprise Value/Ebitda
-14.72

Technicals

Beta
1.41
50 Day MA
32.48
200 Day MA
38.55

Institutional Holdings

Vanguard Group Inc

9.59%

State Street Corporation

4.96%

JPMorgan Chase & Co

2.83%

AllianceBernstein L.P.

2.64%

FMR Inc

2.59%

Amvescap Plc.

2.08%

Discover more

Frequently Asked Questions

What is Arrowhead Pharmaceuticals, Inc. share price today?

Can Indians buy Arrowhead Pharmaceuticals, Inc. shares?

How can I buy Arrowhead Pharmaceuticals, Inc. shares from India?

Can Fractional shares of Arrowhead Pharmaceuticals, Inc. be purchased?

What are the documents required to start investing in Arrowhead Pharmaceuticals, Inc. stocks?

What are today’s High and Low prices of Arrowhead Pharmaceuticals, Inc.?

What are today’s traded volumes of Arrowhead Pharmaceuticals, Inc.?

What is today’s market capitalisation of Arrowhead Pharmaceuticals, Inc.?

What is the 52 Week High and Low Range of Arrowhead Pharmaceuticals, Inc.?

How much percentage Arrowhead Pharmaceuticals, Inc. is down from its 52 Week High?

How much percentage Arrowhead Pharmaceuticals, Inc. is up from its 52 Week low?

What are the historical returns of Arrowhead Pharmaceuticals, Inc.?

Who is the Chief Executive Officer (CEO) of Arrowhead Pharmaceuticals, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*